mc22gzj | Knowledge4COVID-19

Property	Value
?:abstract	As COVID-19 vaccines and therapies emerge, critical questions remain about access and affordability around the world.
?:creator	<https://research.tib.eu/covid-19/entity/Meyer%2C_Harris>
?:doi	10.1377/hlthaff.2020.01732
?:doi	<https://research.tib.eu/covid-19/entity/10.1377/hlthaff.2020.01732>
?:journal	Health_affairs
?:license	unk
?:pmid	<https://research.tib.eu/covid-19/entity/32986500.0>
?:pmid	32986500.0
?:publication_isRelatedTo_Disease	<https://research.tib.eu/covid-19/entity/COVID-19>
?:source	Medline
?:title	After A COVID-19 Vaccine: Collaboration Or Competition?
?:type	<https://research.tib.eu/covid-19/vocab/Publication>
?:year	2020-09-28

Metadata

Anon_0

<http://www.w3.org/1999/02/22-rdf-syntax-ns#type>

<http://purl.org/net/provenance/ns#DataItem>

<http://www.w3.org/1999/02/22-rdf-syntax-ns#type>

<http://www.w3.org/2004/03/trix/rdfg-1/Graph>

<http://xmlns.com/foaf/0.1/primaryTopic>

<https://research.tib.eu/covid-19/entity/4mc22gzj>

<http://xmlns.com/foaf/0.1/topic>

Anon_0

<http://www.ontologydesignpatterns.org/cp/owl/informationrealization.owl#realizes>

<https://research.tib.eu/covid-19/data/entity/4mc22gzj>

<http://purl.org/net/provenance/ns#createdBy>

Anon_1 (more)

expand all